We are live on ! Find out more
ABBV icon

AbbVie
ABBV

2,655 hedge funds and large institutions have $127B invested in AbbVie in 2021 Q3 according to their latest regulatory filings, with 117 funds opening new positions, 1,346 increasing their positions, 872 reducing their positions, and 97 closing their positions.

New
Increased
Maintained
Reduced
Closed

54% more repeat investments, than reductions

Existing positions increased: 1,346 | Existing positions reduced: 872

21% more first-time investments, than exits

New positions opened: 117 | Existing positions closed: 97

0.36% less ownership

Funds ownership: 67.05% → 66.69% (-0.36%)

1% less funds holding

Funds holding: 2,677 → 2,655 (-22)

1% less call options, than puts

Call options by funds: $2.19B | Put options by funds: $2.22B

5% less capital invested

Capital invested by funds: $133B → $127B (-$6.15B)

4% less funds holding in top 10

Funds holding in top 10: 139 → 134 (-5)

Holders
2,655
Holders Change
-22
Holders Change %
-0.82%
% of All Funds
46.47%
Holding in Top 10
134
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-3.6%
% of All Funds
2.35%
New
117
Increased
1,346
Reduced
872
Closed
97
Calls
$2.19B
Puts
$2.22B
Net Calls
-$32.5M
Net Calls Change
+$47.7M

Top Buyers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
+$1.02B
2
BlackRock
BlackRock
New York
+$485M
3
Goldman Sachs
Goldman Sachs
New York
+$346M
4
Ameriprise
Ameriprise
Minnesota
+$325M
5
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
+$278M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$1.58B
2
Berkshire Hathaway
Berkshire Hathaway
Nebraska
-$700M
3
OAG
Orbis Allan Gray
Bermuda
-$414M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$319M
5
Winslow Capital Management
Winslow Capital Management
Minnesota
-$268M
Name Holding Trade Value Shares
Change 		Change in
Stake
LS
1201
Leelyn Smith
Illinois
$2.43M +$16.1K +141 +0.6%
LSA
1202
L & S Advisors
California
$2.43M -$5.18M -45,327 -67%
MPIA
1203
Mountain Pacific Investment Advisers
Idaho
$2.42M -$79.2K -693 -3%
BCM
1204
Breiter Capital Management
Florida
$2.41M +$112K +980 +5%
WA
1205
Wambolt & Associates
Colorado
$2.41M +$235K +2,055 +10%
EP
1206
EPIQ Partners
Minnesota
$2.41M +$440K +3,850 +21%
RPSA
1207
Richard P. Slaughter Associates
Texas
$2.4M -$170K -1,491 -6%
IFWM
1208
Institute for Wealth Management
Colorado
$2.4M +$39.2K +343 +2%
PCA
1209
Providence Capital Advisors
North Carolina
$2.4M +$808K +7,075 +47%
IEFM
1210
IQ EQ Fund Management
Ireland
$2.4M -$651K -5,701 -20%
RIM
1211
Regent Investment Management
Kentucky
$2.4M +$106K +929 +4%
TCA
1212
Transcend Capital Advisors
New Jersey
$2.4M +$300K +2,626 +14%
CIP
1213
Cornerstone Investment Partners
Georgia
$2.39M -$127K -1,110 -5%
CP
1214
Clayton Partners
California
$2.39M -$914 -8 -0%
WA
1215
Wealth Alliance
New York
$2.38M +$66K +578 +3%
LP
1216
LMR Partners
United Kingdom
$2.38M +$1.28M +11,200 +103%
EF
1217
Exeter Financial
Arizona
$2.38M +$11.4K +100 +0.5%
SACTSONJ
1218
Supplemental Annuity Collective Trust (SACT) of New Jersey
New Jersey
$2.38M – – –
BCP
1219
Blackhawk Capital Partners
Wisconsin
$2.38M +$324K +2,839 +15%
SFP
1220
Shepherd Financial Partners
Massachusetts
$2.37M +$2.74K +24 +0.1%
VBCG
1221
Valley Brook Capital Group
Pennsylvania
$2.36M -$128K -1,123 -5%
GCMG
1222
Gyroscope Capital Management Group
Florida
$2.36M – – –
BFA
1223
Benedict Financial Advisors
Georgia
$2.35M +$517K +4,526 +26%
PIM
1224
Perpetual Investment Management
Australia
$2.35M – – –
LJAC
1225
L.J. Altfest & Co
New York
$2.35M +$332K +2,904 +15%
47 48
49
50 51

ABBV Hedge Fund Activity: Q3 2021 in Review

2,655 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in AbbVie (ABBV) for Q3 2021, worth a combined $127B — down 4.6% from $133B a quarter earlier.

Buyers outnumbered sellers: 117 funds opened new ABBV positions and 97 closed out — a net gain of 20 holders — while 1,346 added to existing stakes and 872 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $1.02B. The largest seller was Fidelity Investments, cutting an estimated $1.58B.

  • 2,655 institutional investors held AbbVie (ABBV) as of Q3 2021, down from 2,677 in Q2 2021.
  • Funds reported $127B of AbbVie stock for Q3 2021, down 4.6% quarter-over-quarter.
  • 117 funds opened new AbbVie positions in Q3 2021 and 97 closed out, a net change of +20 holders.
  • The largest AbbVie buyer in Q3 2021 was JP Morgan Chase, an estimated $1.02B added.
  • The largest AbbVie seller in Q3 2021 was Fidelity Investments, an estimated $1.58B sold.

Based on aggregated 13F filings for Q3 2021.